Pharma BD Deal Intelligence
Merck & Co. Inc. / Rosetta Inpharmatics Inc.
2001 · Acquisition/Merger · $540M · Complete
Announcement Sentiment
88
Strongly positive
All-stock; 0.2352 Merck shares per Rosetta share ($18/share). Original announce value ~$620M, net equity ~$540M. Genomics/microarray informatics platform.
Key facts
Announced Jul 19, 2001 Deal value $540M Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
The Pharma Closeout — Deal Intelligence Database.
Announcement Sentiment and Outcome Score from sourced facts.Home ·
Deals ·
Methodology ·
About